Weight Effects of Doxazosin, Bupropion, and Hydroxyzine
Doxazosin causes weight gain, bupropion causes weight loss, and hydroxyzine (a first-generation antihistamine) likely causes weight gain.
Doxazosin (Alpha-Blocker)
Doxazosin is associated with significant weight gain and should be avoided in patients with weight concerns. 1
- The weight gain occurs primarily through extracellular fluid volume expansion rather than increased adiposity 1
- Alpha-blockers as a class are also associated with asthenia (weakness/fatigue), which may contribute to weight gain by reducing energy expenditure and altering energy balance 1
- This was demonstrated in the ALLHAT trial, where doxazosin showed significantly increased risk for congestive heart failure compared to chlorthalidone, along with notable weight gain 1
Clinical recommendation: If treating hypertension in patients concerned about weight, prefer ACE inhibitors, ARBs, or calcium channel blockers, which are weight-neutral 1
Bupropion (Norepinephrine-Dopamine Reuptake Inhibitor)
Bupropion is the only antidepressant that consistently promotes weight loss and is FDA-approved for weight management. 1
- Clinical trials demonstrate bupropion decreases body weight by suppressing appetite and reducing food cravings 1
- FDA-approved in 2014 (combined with naltrexone as Contrave) specifically for chronic weight management 1
- Weight loss magnitude: 1.3 kg in meta-analysis 2, with 14-23% of patients losing >5 lbs in clinical trials 3
- Recent large observational study (183,118 patients) confirmed bupropion showed the least weight gain among 8 first-line antidepressants, with 0.22 kg less weight gain than sertraline at 6 months and 15% reduced risk of gaining ≥5% baseline weight 4
Important caveat: Bupropion is activating and can exacerbate anxiety or be inappropriate for bipolar disorder, so clinical appropriateness must guide selection 1
Hydroxyzine (First-Generation Antihistamine)
Hydroxyzine likely causes weight gain, though evidence quality is limited. 1
- The more potent the antihistamine, the greater the potential for weight gain 1
- First-generation (sedating) antihistamines that act centrally are more likely to promote weight gain than second/third-generation non-sedating antihistamines 1
- Mechanism: Weight gain occurs via antagonism of hypothalamic H1 receptors, as demonstrated in antipsychotic medication studies 1
- These agents cross the blood-brain barrier and affect central appetite regulation, unlike newer antihistamines that are selective for peripheral H1 receptors 1
Clinical recommendation: When antihistamines are needed in weight-conscious patients, consider second/third-generation non-sedating antihistamines or alternatives like decongestants (pseudoephedrine), which are not associated with weight gain 1
Summary Algorithm
For patients with weight concerns:
- Avoid doxazosin - causes fluid retention and weight gain; use ACE-I/ARB/CCB for hypertension instead
- Consider bupropion - only antidepressant that promotes weight loss (if clinically appropriate for depression/anxiety profile)
- Avoid hydroxyzine - first-generation antihistamine likely causes weight gain; use second-generation antihistamines or decongestants instead